Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

CCDC175 Inhibitors

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent kinase inhibitor that can affect various signaling pathways, potentially altering the phosphorylation status of CCDC175 or its interacting partners.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that can disrupt Akt signaling, possibly affecting CCDC175 activity if it is associated with the PI3K/Akt pathway.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

An inhibitor of MEK, which could affect the MAPK/ERK pathway, potentially influencing the activity of CCDC175 if it is involved in this signaling cascade.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Targets p38 MAPK, possibly altering the activity of CCDC175 if it is regulated by stress response pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Another MEK inhibitor that can disrupt MAPK/ERK signaling, potentially affecting CCDC175 activity if it is connected to this pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can alter cell growth and proliferation, potentially affecting CCDC175 if it plays a role in these processes.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, which could modify cellular responses and affect CCDC175 if it is regulated by JNK signaling.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that can affect protein degradation pathways, potentially influencing CCDC175 stability or turnover.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Another proteasome inhibitor that can lead to altered protein levels, possibly affecting CCDC175 indirectly.

Zoledronic acid, anhydrous

118072-93-8sc-364663
sc-364663A
25 mg
100 mg
$92.00
$256.00
5
(0)

This bisphosphonate interferes with bone resorption and calcium signaling, which could affect CCDC175 if it is involved in these processes.